Merck Reorganizes Human Health Business to Drive Commercial Success
Merck Evolves Structure to Enhance Commercial Execution and Portfolio Growth In an industry where the pace of innovation and market dynamics are constantly evolving, how can pharmaceutical companies ensure they stay ahead? Merck known as MSD outside of the United States and…
Gilead Sciences Acquires Arcellx for $7.8 Billion to Advance Cancer Immunotherapies
Gilead Sciences Seals $7.8 Billion Deal for Arcellx to Boost CAR T-Cell Therapy In the rapidly evolving landscape of cancer immunotherapies, where breakthroughs are crucial for patient outcomes, Gilead Sciences, Inc. has made a significant move. The biopharmaceutical giant has announced a…
AOP Health Advances Rare Disease Care With Collaborative Data and Patient Engagement
AOP Health Emphasizes Collaboration and Patient-Centered Information on Rare Disease Day 2026 Why is the diagnosis and treatment of rare diseases so challenging? AOP Health, a global enterprise group with roots in Austria, is dedicated to addressing this critical issue.…
Virion Therapeutics Advances HBV Functional Cure With Novel Immunotherapy
Virion Therapeutics Unveils Promising HBV Treatment at CROI Conference Is the global fight against chronic hepatitis B (CHB) finally turning a corner? Virion Therapeutics, LLC, a clinical-stage biotechnology company, is making significant strides with its novel T cell-based immunotherapy, VRON-0200.…
Exact Sciences Corporation Secures Shareholder Approval for Abbott Acquisition
Exact Sciences Corporation Gains Overwhelming Shareholder Support for Abbott Deal In the rapidly evolving landscape of cancer diagnostics, where precision and speed are paramount, Exact Sciences Corporation has taken a significant step forward. The company, a leading provider of cancer…
Pulse Biosciences Grants Equity Awards to New Employees to Boost Innovation
Pulse Biosciences Awards Equity to New Hires to Drive Growth and Innovation In the competitive landscape of biotechnology, where innovation and talent retention are paramount, Pulse Biosciences, Inc. stands out as a leader in bioelectric medicine. The company, known for…
Science Corporation and Neurosoft Bioelectronics Partner to Accelerate BCI Innovation
Science and Neurosoft Team Up to Reduce BCI Development Costs and Time Science Corporation, a pioneering full-stack neural engineering company, and Neurosoft Bioelectronics, a neural data company, have announced a strategic partnership to grant Neurosoft access to Science’s full stack…
CUPE Nova Scotia Calls for Fair Deal for Long Term Care Workers
Union President Demands Premier Houston to Invest in Public Services Why is the Nova Scotia government prioritizing private contracts over public service workers? CUPE Nova Scotia, a union representing long-term care workers, is demanding Premier Tim Houston to offer a…
ALIS Releases First-of-Its-Kind Clinical Benchmarking Report for Senior Living
ALIS Unveils Comprehensive Clinical and Operational Insights for Senior Living Communities In an industry where data-driven decisions can mean the difference between thriving and merely surviving, ALIS is setting a new standard. The leading senior living intelligent eHR software company…
WestFax Debuts Intelligent Document Automation Platform Tailored to Healthcare
WestFax Launches AI-Powered Intelligent Document Processing Platform for Healthcare WestFax, a provider of HIPAA-compliant cloud fax and healthcare document exchange solutions, today announced the official launch of WestFax Comprehend, an AI-powered Intelligent Document Processing (IDP) platform designed to automate medical…
Savara Reports FDA Filing of BLA for MOLBREEVI in Autoimmune Pulmonary Alveolar Proteinosis
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Savara Inc. a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced the FDA has filed for…
Agenus Shares Biomarker Findings Highlighting Survival Differences in MSS mCRC and Cold Tumors with BOT+BAL
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL Agenus Inc. a leader in immuno-oncology, today announced new translational and clinical biomarker data from its Phase 1b C-800-01 trial (NCT03860272) evaluating…